Cite
HARVARD Citation
Pedersen, S. et al. (2013). THU0366 Efficacy of Adalimumab in Patients with Axial Spondyloarthritis: Results of an Investigator-Initiated 12-Weeks Randomized Double-Blind Placebo Controlled Trial with a 12 Weeks Open-Label Extension Phase. Annals of the rheumatic diseases. p. A289. [Online].